Ads
related to: johnson & johnson- The J&J Credo
Putting the needs of the
people we serve first.
- Latest news
See the latest news from J&J.
Company updates and more.
- Discover J&J
Learn about our strength
in healthcare innovation.
- Our leadership team
Meet the J&J Executive Committee
& our Board of Directors.
- The J&J Credo
Search results
J&J’s Nisha Johnson on Ethizia wound-sealing patch, biosurgery market
MedTech Dive via Yahoo Finance· 4 days agoJohnson & Johnson received a CE mark in November for Ethizia, a hemostatic sealing patch designed to...
Johnson & Johnson's Drug Seltorexant Aces Late-Stage Depression Trial
Benzinga· 3 days agoSeltorexant is an investigational first-in-class selective antagonist of the human orexin-2 receptor...
Wells Fargo reiterates Equal Weight on JNJ post KVUE shares divestiture By Investing.com
Investing.com· 3 days agoOn Wednesday, Wells Fargo (NYSE:WFC) reiterated its Equal Weight rating on Johnson & Johnson...
3 Stocks That Could Be Easy Wealth Builders
The Motley Fool via AOL· 2 days agoThis trio of familiar household names should let you build wealth for decades to come -- without ever losing sleep over their business prospects. You'll never find a more intriguing and diverse ...
RYBREVANT® (amivantamab-vmjw) plus lazertinib is the only chemotherapy-free regimen showing longer...
telegraphherald.com· 19 hours agoJohnson & Johnson today announced new data from the Phase 3 MARIPOSA study demonstrating the benefit of first-line treatment with RYBREVANT® (amivantamab-vmjw ...
Johnson & Johnson: An Exploration into Its Intrinsic Value
GuruFocus.com via Yahoo Finance· 5 days agoIn this article, we will take a look into Johnson & Johnson's (NYSE:JNJ) DCF analysis, a reliable...
A company insider recently sold 8,891 shares of Johnson & Johnson [JNJ]. Should You Sale? – Knox...
Knox Daily· 2 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Johnson & Johnson shares valued at $1,441,765 ...
J&J antidepressant eases symptoms, improves sleep in key trial
BioPharma Dive via Yahoo Finance· 3 days agoDive Brief: A new kind of antidepressant eased symptoms and improved sleep among adults enrolled in...
The Most Profitable Biotechnology Company in the World
Insider Monkey via Yahoo Finance· 23 hours agoIn this article, we will be taking a look at the most profitable biotechnology company in the world. If you want to learn about more, head straight to the 15 Most Profitable Biotechnology Companies ...
J&J to acquire experimental eczema drug for $1.25B
NJBIZ· 2 days agoJohnson & Johnson plans to pay $1.25 billion for the rights to an experimental eczema treatment. The New Brunswick-based pharma giant announced the...
Ad
related to: johnson & johnson
